To determine whether the CDCA8 expression is correlated with the malignant progression and clinical outcomes of gliomas, we detected the CDCA8 level in glioma IHC samples and evaluated the overall survival and disease-free survival outcomes by Kaplan–Meier survival analysis. This evidence concerns the gene CDCA8 and central nervous system cancer.